KOTMY yields 2.56% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, KOTMY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of KOTMY + JNJ for your $10,000?
Koito Manufacturing Co., Ltd. manufactures and markets automotive lighting equipment, electrical equipment, and other products in Japan, North America, China, rest of Asia, Europe, and internationally. The company provides automotive lighting products and accessories, including LED, discharge, and halogen headlamps, as well as fog lamps; and signaling lamps/other lighting products comprising LED rear combination, side turn signal, and high-mounted stop lamps. It also offers aircraft lighting and other equipment, such as interior and exterior lights, and caution warning panels, as well as electrical, hydraulic, and mechanical equipment; and ship lights/special products consisting of LED marine lamps and destination indicators. In addition, it manufactures and markets electronic components, electrical devices, telecommunications equipment, precision machinery, miniature bulbs, electrical equipment, resin metal molds, railroad car control equipment, and road traffic signals and traffic control systems, as well as seats for railroad cars, etc. Further, the company provides transportation and logistics, and insurance agency services; and maintains traffic signals and safety equipment. Koito Manufacturing Co., Ltd. was founded in 1915 and is headquartered in Tokyo, Japan.
Full KOTMY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.